Maynard Um
-
-
-
-
-
-
-
Cytosorbents (CTSO) Tops Q3 EPS by 1c, Misses on Revenue
-
-
-
-
-
-
-
Cytosorbents (CTSO) Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025
-
-
-
-
-
-
-
Cytosorbents (CTSO) Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants
-
-
-
-
-
-
-
B.Riley Reiterates Buy Rating on CytoSorbents (CTSO)
-
-
-
-
-
-
-
Cytosorbents (CTSO) Enters $20M Credit Facility
-
444,173 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

